Onkourologiya

根据国际医学期刊编辑委员会（ICMJE）的建议，只有对研究的构思与设计或数据的分析与解释作出重大贡献、积极参与论文撰写或作出关键修改、参与最终待发表版本的批准并愿意对文章内容负责的人，才有权被称为作者。 模型中文摘要

According to the recommendations of the ICMJE, the right to be referred as the author have those persons who made significant contribution to the conception and design of the study or in the data analysis and its interpretation, actively participated in drafting the article or making fundamental changes, participated in the final approval of the version that is to be published and ready to take re…

文章末尾必须说明所有作者的利害冲突。利害冲突指任何可能影响结果、数据解释及其客观认知的关系和/或个人利益，例如与任何组织的财务关系与合作（如收取报酬、教育资助、参加专家委员会、会员身份、工作关系、咨询工作、私有财产中的店铺所有权或其他利益），或非财务利益（如个人或职业关系、相识等）。 模型中文摘要

At the end of the article you must specify conflicts of interest for all authors. Conflict of interest implies the existence of any relations and/or personal interest that potentially can affect results, interpretation of data, its objective perception, such as financial relations and cooperation with any organizations (e.g., receipt of fees, educational grants, participation in expert councils, m…

Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, addition…

投给《Onkourologiya》（《Cancer Urology》）编辑部的所有科学稿件均强制采用双盲同行评审，即审稿人不知道稿件作者身份，作者也不与审稿人保持任何联系。同行评审由编委会成员及受邀担任独立审稿人的俄罗斯及国际相关领域权威专家进行；主编、副主编或科学编辑选择审稿人。 模型中文摘要

A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of "Onkourologiya" (“Cancer Urology”). This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer. Members of the editorial board and leading Russian and international experts in corresponding a…

禁止发表含有文字、观点、数据剽窃的作品，作者应提交完全原创的作品；他人成果应恰当引用或引述，已发表文字的引用应以直接引语形式书写并必须注明原始出处。编辑部使用查重软件 Antiplagiat 和 Google Scholar 对投稿进行筛查；如发现非法挪用的文字和图形元素或文本原创性系数过低，将作相应处理。 模型中文摘要

Publication of works containing plagiarism of text, ideas, data is prohibited. Authors should submit fully original works. Results of other authors’ work should be appropriately cited or quoted; quotations of a text previously published should be written as the direct speech with the obligatory indication of the original source. The editorial board of the journal checks the material using plagiari…

在《Cancer Urology》接受和发表之前，作者可以在个人或公共网站上以预印本形式公开其投稿；作为投稿流程的一部分，作者须确认该稿件未曾发表、也未曾投往他处。稿件在本刊发表后，建议作者在个人或公共网站上分享文章时使用期刊网站上的文章链接。 模型中文摘要

Prior to acceptance and publication in "Cancer Urology", authors may make their submissions available as preprints on personal or public websites. As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in "Cancer Urology" we suggest that the link to the article on journal's …